Selected research
Market Structure
Global In Vivo Pharmacology Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global In Vivo Pharmacology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of In Vivo Pharmacology Service include NuChem Sciences Inc, Eurofins Discovery, Oncodesign Services, Jubilant Biosys, Pharmaron, Melior Discovery, NUVISAN GmbH, Porsolt and Sygnature Discovery, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global In Vivo Pharmacology Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of In Vivo Pharmacology Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents In Vivo Pharmacology Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In Vivo Pharmacology Service market size, projected growth trends, production technologies, key applications, and end-use industries.
In Vivo Pharmacology Service Segment by Company
NuChem Sciences Inc
Eurofins Discovery
Oncodesign Services
Jubilant Biosys
Pharmaron
Melior Discovery
NUVISAN GmbH
Porsolt
Sygnature Discovery
Aurigene Pharmaceutical Services Ltd
Reaction Biology
Addexbio
Paraza Pharma, Inc
Aragen Life Sciences Ltd
Dalriada
Biocytogen
Charles River Laboratories
Pharmacelsu
HitGen Inc
TCG Lifesciences
In Vivo Pharmacology Service Segment by Type
Small Molecule Screening
Large Molecule Screening
Others
In Vivo Pharmacology Service Segment by Application
Neurological Diseases
Cardiovascular and Metabolic Diseases
Skin Diseases
Others
In Vivo Pharmacology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vivo Pharmacology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vivo Pharmacology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vivo Pharmacology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In Vivo Pharmacology Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vivo Pharmacology Service industry.
Chapter 3: Detailed analysis of In Vivo Pharmacology Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vivo Pharmacology Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global In Vivo Pharmacology Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Small Molecule Screening
Table 3. Key Players of Large Molecule Screening
Table 4. Key Players of Others
Table 4. Global In Vivo Pharmacology Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Neurological Diseases
Table 6. Key Players of Cardiovascular and Metabolic Diseases
Table 7. Key Players of Skin Diseases
Table 8. Key Players of Others
Table 9. Global In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 10. Global In Vivo Pharmacology Service Market Size by Region (2021-2026) & (US$ Million)
Table 11. Global In Vivo Pharmacology Service Market Share by Region (2021-2026)
Table 12. Global In Vivo Pharmacology Service Market Size by Region (2027-2032) & (US$ Million)
Table 13. Global In Vivo Pharmacology Service Market Share by Region (2027-2032)
Table 14. In Vivo Pharmacology Service Industry Trends
Table 15. In Vivo Pharmacology Service Industry Drivers
Table 16. In Vivo Pharmacology Service Industry Opportunities and Challenges
Table 17. In Vivo Pharmacology Service Industry Restraints
Table 18. Global In Vivo Pharmacology Service Revenue by Company (US$ Million) & (2021-2026)
Table 19. Global In Vivo Pharmacology Service Revenue Market Share by Company (2021-2026)
Table 20. Global In Vivo Pharmacology Service Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 21. Global In Vivo Pharmacology Service Key Company Head Office and Area Served
Table 22. Global In Vivo Pharmacology Service Company, Product Type & Application
Table 23. Global In Vivo Pharmacology Service Company Establishment Date
Table 24. Global Company Market Concentration Ratio (CR5 and HHI)
Table 25. Global In Vivo Pharmacology Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 26. Global In Vivo Pharmacology Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 28. Global In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 29. Global In Vivo Pharmacology Service Revenue Market Share by Type (2021-2026)
Table 30. Global In Vivo Pharmacology Service Revenue Market Share by Type (2027-2032)
Table 31. Global In Vivo Pharmacology Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 33. Global In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 34. Global In Vivo Pharmacology Service Revenue Market Share by Application (2021-2026)
Table 35. Global In Vivo Pharmacology Service Revenue Market Share by Application (2027-2032)
Table 36. NuChem Sciences Inc Company Information
Table 37. NuChem Sciences Inc Business Overview
Table 38. NuChem Sciences Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 39. NuChem Sciences Inc In Vivo Pharmacology Service Product Portfolio
Table 40. NuChem Sciences Inc Recent Development
Table 41. Eurofins Discovery Company Information
Table 42. Eurofins Discovery Business Overview
Table 43. Eurofins Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 44. Eurofins Discovery In Vivo Pharmacology Service Product Portfolio
Table 45. Eurofins Discovery Recent Development
Table 46. Oncodesign Services Company Information
Table 47. Oncodesign Services Business Overview
Table 48. Oncodesign Services In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 49. Oncodesign Services In Vivo Pharmacology Service Product Portfolio
Table 50. Oncodesign Services Recent Development
Table 51. Jubilant Biosys Company Information
Table 52. Jubilant Biosys Business Overview
Table 53. Jubilant Biosys In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 54. Jubilant Biosys In Vivo Pharmacology Service Product Portfolio
Table 55. Jubilant Biosys Recent Development
Table 56. Pharmaron Company Information
Table 57. Pharmaron Business Overview
Table 58. Pharmaron In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 59. Pharmaron In Vivo Pharmacology Service Product Portfolio
Table 60. Pharmaron Recent Development
Table 61. Melior Discovery Company Information
Table 62. Melior Discovery Business Overview
Table 63. Melior Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 64. Melior Discovery In Vivo Pharmacology Service Product Portfolio
Table 65. Melior Discovery Recent Development
Table 66. NUVISAN GmbH Company Information
Table 67. NUVISAN GmbH Business Overview
Table 68. NUVISAN GmbH In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 69. NUVISAN GmbH In Vivo Pharmacology Service Product Portfolio
Table 70. NUVISAN GmbH Recent Development
Table 71. Porsolt Company Information
Table 72. Porsolt Business Overview
Table 73. Porsolt In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 74. Porsolt In Vivo Pharmacology Service Product Portfolio
Table 75. Porsolt Recent Development
Table 76. Sygnature Discovery Company Information
Table 77. Sygnature Discovery Business Overview
Table 78. Sygnature Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 79. Sygnature Discovery In Vivo Pharmacology Service Product Portfolio
Table 80. Sygnature Discovery Recent Development
Table 81. Aurigene Pharmaceutical Services Ltd Company Information
Table 82. Aurigene Pharmaceutical Services Ltd Business Overview
Table 83. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 84. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product Portfolio
Table 85. Aurigene Pharmaceutical Services Ltd Recent Development
Table 86. Reaction Biology Company Information
Table 87. Reaction Biology Business Overview
Table 88. Reaction Biology In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 89. Reaction Biology In Vivo Pharmacology Service Product Portfolio
Table 90. Reaction Biology Recent Development
Table 91. Addexbio Company Information
Table 92. Addexbio Business Overview
Table 93. Addexbio In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 94. Addexbio In Vivo Pharmacology Service Product Portfolio
Table 95. Addexbio Recent Development
Table 96. Paraza Pharma, Inc Company Information
Table 97. Paraza Pharma, Inc Business Overview
Table 98. Paraza Pharma, Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 99. Paraza Pharma, Inc In Vivo Pharmacology Service Product Portfolio
Table 100. Paraza Pharma, Inc Recent Development
Table 101. Aragen Life Sciences Ltd Company Information
Table 102. Aragen Life Sciences Ltd Business Overview
Table 103. Aragen Life Sciences Ltd In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 104. Aragen Life Sciences Ltd In Vivo Pharmacology Service Product Portfolio
Table 105. Aragen Life Sciences Ltd Recent Development
Table 106. Dalriada Company Information
Table 107. Dalriada Business Overview
Table 108. Dalriada In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 109. Dalriada In Vivo Pharmacology Service Product Portfolio
Table 110. Dalriada Recent Development
Table 111. Biocytogen Company Information
Table 112. Biocytogen Business Overview
Table 113. Biocytogen In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 114. Biocytogen In Vivo Pharmacology Service Product Portfolio
Table 115. Biocytogen Recent Development
Table 116. Charles River Laboratories Company Information
Table 117. Charles River Laboratories Business Overview
Table 118. Charles River Laboratories In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 119. Charles River Laboratories In Vivo Pharmacology Service Product Portfolio
Table 120. Charles River Laboratories Recent Development
Table 121. Pharmacelsu Company Information
Table 122. Pharmacelsu Business Overview
Table 123. Pharmacelsu In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 124. Pharmacelsu In Vivo Pharmacology Service Product Portfolio
Table 125. Pharmacelsu Recent Development
Table 126. HitGen Inc Company Information
Table 127. HitGen Inc Business Overview
Table 128. HitGen Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 129. HitGen Inc In Vivo Pharmacology Service Product Portfolio
Table 130. HitGen Inc Recent Development
Table 131. TCG Lifesciences Company Information
Table 132. TCG Lifesciences Business Overview
Table 133. TCG Lifesciences In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 134. TCG Lifesciences In Vivo Pharmacology Service Product Portfolio
Table 135. TCG Lifesciences Recent Development
Table 136. North America In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 137. North America In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 138. North America In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 139. North America In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 140. North America In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 141. North America In Vivo Pharmacology Service Market Size by Country (2021-2026)
Table 142. North America In Vivo Pharmacology Service Market Size by Country (2027-2032)
Table 143. Europe In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 144. Europe In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 145. Europe In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 146. Europe In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 147. Europe In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 148. Europe In Vivo Pharmacology Service Market Size by Country (2021-2026)
Table 149. Europe In Vivo Pharmacology Service Market Size by Country (2027-2032)
Table 150. China In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 151. China In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 152. China In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 153. China In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 154. Asia In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 155. Asia In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 156. Asia In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 157. Asia In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 158. Asia In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 159. Asia In Vivo Pharmacology Service Market Size by Country (2021-2026)
Table 160. Asia In Vivo Pharmacology Service Market Size by Country (2027-2032)
Table 161. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million)
Table 162. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Type (2027-2032) & (US$ Million)
Table 163. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million)
Table 164. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Application (2027-2032) & (US$ Million)
Table 165. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 166. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021-2026)
Table 167. South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2027-2032)
Table 168. Research Programs/Design for This Report
Table 169. Authors List of This Report
Table 170. Secondary Sources
Table 171. Primary Sources
List of Figures
Figure 1. In Vivo Pharmacology Service Product Image
Figure 2. Global In Vivo Pharmacology Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global In Vivo Pharmacology Service Market Share by Type: 2025 VS 2032
Figure 4. Small Molecule Screening Image
Figure 5. Large Molecule Screening Image
Figure 6. Others Image
Figure 7. Global In Vivo Pharmacology Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 8. Global In Vivo Pharmacology Service Market Share by Application: 2025 VS 2032
Figure 9. Neurological Diseases Image
Figure 10. Cardiovascular and Metabolic Diseases Image
Figure 11. Skin Diseases Image
Figure 12. Others Image
Figure 13. Global In Vivo Pharmacology Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 14. Global In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 15. Global In Vivo Pharmacology Service Market Share by Region: 2025 VS 2032
Figure 16. Years Considered
Figure 17. Global In Vivo Pharmacology Service Market Share by Players in 2025
Figure 18. Global Top 5 and 10 In Vivo Pharmacology Service Players Market Share by Revenue in 2025
Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global In Vivo Pharmacology Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global In Vivo Pharmacology Service Revenue Market Share by Type (2021-2032)
Figure 22. Global In Vivo Pharmacology Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 23. Global In Vivo Pharmacology Service Revenue Market Share by Application (2021-2032)
Figure 24. North America In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 25. North America In Vivo Pharmacology Service Market Share by Type (2021-2032)
Figure 26. North America In Vivo Pharmacology Service Market Share by Application (2021-2032)
Figure 27. North America In Vivo Pharmacology Service Market Share by Country (2021-2032)
Figure 28. United States In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 29. Canada In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 30. Mexico In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 31. Europe In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 32. Europe In Vivo Pharmacology Service Market Share by Type (2021-2032)
Figure 33. Europe In Vivo Pharmacology Service Market Share by Application (2021-2032)
Figure 34. Europe In Vivo Pharmacology Service Market Share by Country (2021-2032)
Figure 35. Germany In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 36. France In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 37. U.K. In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 38. Italy In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 39. Russia In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 40. Nordic Countries In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 41. China In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 42. China In Vivo Pharmacology Service Market Share by Type (2021-2032)
Figure 43. China In Vivo Pharmacology Service Market Share by Application (2021-2032)
Figure 44. Asia In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 45. Asia In Vivo Pharmacology Service Market Share by Type (2021-2032)
Figure 46. Asia In Vivo Pharmacology Service Market Share by Application (2021-2032)
Figure 47. Asia In Vivo Pharmacology Service Market Share by Country (2021-2032)
Figure 48. Japan In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 49. South Korea In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 50. Taiwan In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 51. Southeast Asia In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 52. India In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 53. Australia In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 54. South America, Middle East & Africa In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 55. South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Type (2021-2032)
Figure 56. South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Application (2021-2032)
Figure 57. South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021-2032)
Figure 58. Brazil In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 59. South Africa In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 60. Saudi Arabia In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 61. Turkey In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 62. Argentina In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 63. UAE In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 64. Egypt In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 65. Chile In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million)
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Scope & coverage.
Types
- Small Molecule Screening
- Large Molecule Screening
- Others
Applications
- Neurological Diseases
- Cardiovascular and Metabolic Diseases
- Skin Diseases
- Others
Companies covered
- NuChem Sciences Inc
- Eurofins Discovery
- Oncodesign Services
- Jubilant Biosys
- Pharmaron
- Melior Discovery
- NUVISAN GmbH
- Porsolt
- Sygnature Discovery
- Aurigene Pharmaceutical Services Ltd
- Reaction Biology
- Addexbio
- Paraza Pharma, Inc
- Aragen Life Sciences Ltd
- Dalriada
- Biocytogen
- Charles River Laboratories
- Pharmacelsu
- HitGen Inc
- TCG Lifesciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global In Vivo Pharmacology Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Small Molecule Screening
- 1.2.3 Large Molecule Screening
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global In Vivo Pharmacology Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Neurological Diseases
- 1.3.3 Cardiovascular and Metabolic Diseases
- 1.3.4 Skin Diseases
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global In Vivo Pharmacology Service Growth Trends by Region
- 1.5.1 Global In Vivo Pharmacology Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 In Vivo Pharmacology Service Market Size by Region (2021-2026)
- 1.5.3 In Vivo Pharmacology Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global In Vivo Pharmacology Service Market Dynamics
- 2.1 In Vivo Pharmacology Service Industry Trends
- 2.2 In Vivo Pharmacology Service Industry Drivers
- 2.3 In Vivo Pharmacology Service Industry Opportunities and Challenges
- 2.4 In Vivo Pharmacology Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global In Vivo Pharmacology Service Revenue by Company (2021-2026)
- 3.2 Global In Vivo Pharmacology Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global In Vivo Pharmacology Service Key Company Head office and Area Served
- 3.4 Global In Vivo Pharmacology Service Company, Product Type & Application
- 3.5 Global In Vivo Pharmacology Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global In Vivo Pharmacology Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 In Vivo Pharmacology Service Players Market Share by Revenue in 2025
- 3.6.3 2025 In Vivo Pharmacology Service Tier 1, Tier 2, and Tier 3
4 In Vivo Pharmacology Service Market by Type
- 4.1 Global In Vivo Pharmacology Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global In Vivo Pharmacology Service Market Size by Type (2021-2032)
- 4.3 Global In Vivo Pharmacology Service Market Size Share by Type (2021-2032)
5 In Vivo Pharmacology Service Market by Application
- 5.1 Global In Vivo Pharmacology Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global In Vivo Pharmacology Service Market Size by Application (2021-2032)
- 5.3 Global In Vivo Pharmacology Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 NuChem Sciences Inc
- 6.1.1 NuChem Sciences Inc Company Information
- 6.1.2 NuChem Sciences Inc Business Overview
- 6.1.3 NuChem Sciences Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 NuChem Sciences Inc In Vivo Pharmacology Service Product Portfolio
- 6.1.5 NuChem Sciences Inc Recent Developments
- 6.2 Eurofins Discovery
- 6.2.1 Eurofins Discovery Company Information
- 6.2.2 Eurofins Discovery Business Overview
- 6.2.3 Eurofins Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Eurofins Discovery In Vivo Pharmacology Service Product Portfolio
- 6.2.5 Eurofins Discovery Recent Developments
- 6.3 Oncodesign Services
- 6.3.1 Oncodesign Services Company Information
- 6.3.2 Oncodesign Services Business Overview
- 6.3.3 Oncodesign Services In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Oncodesign Services In Vivo Pharmacology Service Product Portfolio
- 6.3.5 Oncodesign Services Recent Developments
- 6.4 Jubilant Biosys
- 6.4.1 Jubilant Biosys Company Information
- 6.4.2 Jubilant Biosys Business Overview
- 6.4.3 Jubilant Biosys In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Jubilant Biosys In Vivo Pharmacology Service Product Portfolio
- 6.4.5 Jubilant Biosys Recent Developments
- 6.5 Pharmaron
- 6.5.1 Pharmaron Company Information
- 6.5.2 Pharmaron Business Overview
- 6.5.3 Pharmaron In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Pharmaron In Vivo Pharmacology Service Product Portfolio
- 6.5.5 Pharmaron Recent Developments
- 6.6 Melior Discovery
- 6.6.1 Melior Discovery Company Information
- 6.6.2 Melior Discovery Business Overview
- 6.6.3 Melior Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Melior Discovery In Vivo Pharmacology Service Product Portfolio
- 6.6.5 Melior Discovery Recent Developments
- 6.7 NUVISAN GmbH
- 6.7.1 NUVISAN GmbH Company Information
- 6.7.2 NUVISAN GmbH Business Overview
- 6.7.3 NUVISAN GmbH In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 NUVISAN GmbH In Vivo Pharmacology Service Product Portfolio
- 6.7.5 NUVISAN GmbH Recent Developments
- 6.8 Porsolt
- 6.8.1 Porsolt Company Information
- 6.8.2 Porsolt Business Overview
- 6.8.3 Porsolt In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Porsolt In Vivo Pharmacology Service Product Portfolio
- 6.8.5 Porsolt Recent Developments
- 6.9 Sygnature Discovery
- 6.9.1 Sygnature Discovery Company Information
- 6.9.2 Sygnature Discovery Business Overview
- 6.9.3 Sygnature Discovery In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sygnature Discovery In Vivo Pharmacology Service Product Portfolio
- 6.9.5 Sygnature Discovery Recent Developments
- 6.10 Aurigene Pharmaceutical Services Ltd
- 6.10.1 Aurigene Pharmaceutical Services Ltd Company Information
- 6.10.2 Aurigene Pharmaceutical Services Ltd Business Overview
- 6.10.3 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product Portfolio
- 6.10.5 Aurigene Pharmaceutical Services Ltd Recent Developments
- 6.11 Reaction Biology
- 6.11.1 Reaction Biology Company Information
- 6.11.2 Reaction Biology Business Overview
- 6.11.3 Reaction Biology In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Reaction Biology In Vivo Pharmacology Service Product Portfolio
- 6.11.5 Reaction Biology Recent Developments
- 6.12 Addexbio
- 6.12.1 Addexbio Company Information
- 6.12.2 Addexbio Business Overview
- 6.12.3 Addexbio In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Addexbio In Vivo Pharmacology Service Product Portfolio
- 6.12.5 Addexbio Recent Developments
- 6.13 Paraza Pharma, Inc
- 6.13.1 Paraza Pharma, Inc Company Information
- 6.13.2 Paraza Pharma, Inc Business Overview
- 6.13.3 Paraza Pharma, Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Paraza Pharma, Inc In Vivo Pharmacology Service Product Portfolio
- 6.13.5 Paraza Pharma, Inc Recent Developments
- 6.14 Aragen Life Sciences Ltd
- 6.14.1 Aragen Life Sciences Ltd Company Information
- 6.14.2 Aragen Life Sciences Ltd Business Overview
- 6.14.3 Aragen Life Sciences Ltd In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Aragen Life Sciences Ltd In Vivo Pharmacology Service Product Portfolio
- 6.14.5 Aragen Life Sciences Ltd Recent Developments
- 6.15 Dalriada
- 6.15.1 Dalriada Company Information
- 6.15.2 Dalriada Business Overview
- 6.15.3 Dalriada In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Dalriada In Vivo Pharmacology Service Product Portfolio
- 6.15.5 Dalriada Recent Developments
- 6.16 Biocytogen
- 6.16.1 Biocytogen Company Information
- 6.16.2 Biocytogen Business Overview
- 6.16.3 Biocytogen In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Biocytogen In Vivo Pharmacology Service Product Portfolio
- 6.16.5 Biocytogen Recent Developments
- 6.17 Charles River Laboratories
- 6.17.1 Charles River Laboratories Company Information
- 6.17.2 Charles River Laboratories Business Overview
- 6.17.3 Charles River Laboratories In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Charles River Laboratories In Vivo Pharmacology Service Product Portfolio
- 6.17.5 Charles River Laboratories Recent Developments
- 6.18 Pharmacelsu
- 6.18.1 Pharmacelsu Company Information
- 6.18.2 Pharmacelsu Business Overview
- 6.18.3 Pharmacelsu In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Pharmacelsu In Vivo Pharmacology Service Product Portfolio
- 6.18.5 Pharmacelsu Recent Developments
- 6.19 HitGen Inc
- 6.19.1 HitGen Inc Company Information
- 6.19.2 HitGen Inc Business Overview
- 6.19.3 HitGen Inc In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 HitGen Inc In Vivo Pharmacology Service Product Portfolio
- 6.19.5 HitGen Inc Recent Developments
- 6.20 TCG Lifesciences
- 6.20.1 TCG Lifesciences Company Information
- 6.20.2 TCG Lifesciences Business Overview
- 6.20.3 TCG Lifesciences In Vivo Pharmacology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 TCG Lifesciences In Vivo Pharmacology Service Product Portfolio
- 6.20.5 TCG Lifesciences Recent Developments
7 North America
- 7.1 North America In Vivo Pharmacology Service Market Size (2021-2032)
- 7.2 North America In Vivo Pharmacology Service Market Size by Type
- 7.2.1 North America In Vivo Pharmacology Service Market Size by Type (2021-2026)
- 7.2.2 North America In Vivo Pharmacology Service Market Size by Type (2027-2032)
- 7.2.3 North America In Vivo Pharmacology Service Market Share by Type (2021-2032)
- 7.3 North America In Vivo Pharmacology Service Market Size by Application
- 7.3.1 North America In Vivo Pharmacology Service Market Size by Application (2021-2026)
- 7.3.2 North America In Vivo Pharmacology Service Market Size by Application (2027-2032)
- 7.3.3 North America In Vivo Pharmacology Service Market Share by Application (2021-2032)
- 7.4 North America In Vivo Pharmacology Service Market Size by Country
- 7.4.1 North America In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America In Vivo Pharmacology Service Market Size by Country (2021-2026)
- 7.4.3 North America In Vivo Pharmacology Service Market Size by Country (2027-2032)
- 7.4.4 North America In Vivo Pharmacology Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe In Vivo Pharmacology Service Market Size (2021-2032)
- 8.2 Europe In Vivo Pharmacology Service Market Size by Type
- 8.2.1 Europe In Vivo Pharmacology Service Market Size by Type (2021-2026)
- 8.2.2 Europe In Vivo Pharmacology Service Market Size by Type (2027-2032)
- 8.2.3 Europe In Vivo Pharmacology Service Market Share by Type (2021-2032)
- 8.3 Europe In Vivo Pharmacology Service Market Size by Application
- 8.3.1 Europe In Vivo Pharmacology Service Market Size by Application (2021-2026)
- 8.3.2 Europe In Vivo Pharmacology Service Market Size by Application (2027-2032)
- 8.3.3 Europe In Vivo Pharmacology Service Market Share by Application (2021-2032)
- 8.4 Europe In Vivo Pharmacology Service Market Size by Country
- 8.4.1 Europe In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe In Vivo Pharmacology Service Market Size by Country (2021-2026)
- 8.4.3 Europe In Vivo Pharmacology Service Market Size by Country (2027-2032)
- 8.4.4 Europe In Vivo Pharmacology Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China In Vivo Pharmacology Service Market Size (2021-2032)
- 9.2 China In Vivo Pharmacology Service Market Size by Type
- 9.2.1 China In Vivo Pharmacology Service Market Size by Type (2021-2026)
- 9.2.2 China In Vivo Pharmacology Service Market Size by Type (2027-2032)
- 9.2.3 China In Vivo Pharmacology Service Market Share by Type (2021-2032)
- 9.3 China In Vivo Pharmacology Service Market Size by Application
- 9.3.1 China In Vivo Pharmacology Service Market Size by Application (2021-2026)
- 9.3.2 China In Vivo Pharmacology Service Market Size by Application (2027-2032)
- 9.3.3 China In Vivo Pharmacology Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia In Vivo Pharmacology Service Market Size (2021-2032)
- 10.2 Asia In Vivo Pharmacology Service Market Size by Type
- 10.2.1 Asia In Vivo Pharmacology Service Market Size by Type (2021-2026)
- 10.2.2 Asia In Vivo Pharmacology Service Market Size by Type (2027-2032)
- 10.2.3 Asia In Vivo Pharmacology Service Market Share by Type (2021-2032)
- 10.3 Asia In Vivo Pharmacology Service Market Size by Application
- 10.3.1 Asia In Vivo Pharmacology Service Market Size by Application (2021-2026)
- 10.3.2 Asia In Vivo Pharmacology Service Market Size by Application (2027-2032)
- 10.3.3 Asia In Vivo Pharmacology Service Market Share by Application (2021-2032)
- 10.4 Asia In Vivo Pharmacology Service Market Size by Country
- 10.4.1 Asia In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia In Vivo Pharmacology Service Market Size by Country (2021-2026)
- 10.4.3 Asia In Vivo Pharmacology Service Market Size by Country (2027-2032)
- 10.4.4 Asia In Vivo Pharmacology Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa In Vivo Pharmacology Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Type
- 11.2.1 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Application
- 11.3.1 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country
- 11.4.1 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst